Michael Kody
Director of Finance/CFO at Pharmaceutical Associates, Inc.
Michael Kody active positions
Companies | Position | Start | End |
---|---|---|---|
Felicitex Therapeutics, Inc.
Felicitex Therapeutics, Inc. Miscellaneous Commercial ServicesCommercial Services Felicitex Therapeutics, Inc. is a pre-clinical stage oncology drug development company developing therapies against cancer and diabetes. It operates through the Felicitex Business and TraMeta segments. The Felicitex Business segment handles the design and patents of small molecules and related methods to selectively disrupt dormant cancer cells in a manner that is specific to the disease and tissue context. The TarMeta segment built a drug discovery platform for small molecule inhibitors targeting cancer. The company was founded by Maria Vilenchik and Michael Frid on May 4, 2012 and is headquartered in Natick, MA. | Director/Board Member | - | - |
Pharmaceutical Associates, Inc.
Pharmaceutical Associates, Inc. Pharmaceuticals: MajorHealth Technology Part of Beach Products, Inc., Pharmaceutical Associates, Inc. is a leading manufacturer and marketer of generic liquid pharmaceuticals. The private company is based in Greenville, SC. The company has been producing better-targeted suspensions, oral solutions, elixirs, syrups, and liquids for almost 50 years. The company offers standard bottle packaging and ready-to-dispense packaging to meet the unique needs of retail chains, independent pharmacies, hospitals, long-term care facilities, and government agencies. Pharmaceutical Associates was the first independent manufacturer to develop vertically integrated unit-dose (ud) packaging and the first to offer complete lines of hard-to-find liquid products in both out-patient and ud packaging. The CEO of the company is Kurt J. Orlofski. | Director of Finance/CFO | 2020-12-31 | - |
Career history of Michael Kody
Former positions of Michael Kody
Companies | Position | Start | End |
---|---|---|---|
CENCORA, INC. | Corporate Officer/Principal | 2006-12-31 | 2016-12-31 |
PricewaterhouseCoopers LLP
PricewaterhouseCoopers LLP Miscellaneous Commercial ServicesCommercial Services PricewaterhouseCoopers LLC provides assurance, tax and advisory services. Its services include audit and assurance, consulting, deals, human resources, legal, tax, and family business. The firm also offers accountability, risk management, structuring, mergers and acquisitions, and performance and process improvement. The company was founded in 1998 and is headquartered in Buffalo, NY. | Comptroller/Controller/Auditor | 1990-12-31 | 2006-12-31 |
Training of Michael Kody
University of Michigan | Undergraduate Degree |
Statistics
International
United States | 5 |
Netherlands | 2 |
Operational
Corporate Officer/Principal | 2 |
Director/Board Member | 1 |
Director of Finance/CFO | 1 |
Sectoral
Commercial Services | 3 |
Distribution Services | 2 |
Health Technology | 2 |
Positions held
Active
Inactive
Listed companies
Private companies
Linked companies
Listed companies | 1 |
---|---|
CENCORA, INC. | Distribution Services |
Private companies | 3 |
---|---|
PricewaterhouseCoopers LLP
PricewaterhouseCoopers LLP Miscellaneous Commercial ServicesCommercial Services PricewaterhouseCoopers LLC provides assurance, tax and advisory services. Its services include audit and assurance, consulting, deals, human resources, legal, tax, and family business. The firm also offers accountability, risk management, structuring, mergers and acquisitions, and performance and process improvement. The company was founded in 1998 and is headquartered in Buffalo, NY. | Commercial Services |
Felicitex Therapeutics, Inc.
Felicitex Therapeutics, Inc. Miscellaneous Commercial ServicesCommercial Services Felicitex Therapeutics, Inc. is a pre-clinical stage oncology drug development company developing therapies against cancer and diabetes. It operates through the Felicitex Business and TraMeta segments. The Felicitex Business segment handles the design and patents of small molecules and related methods to selectively disrupt dormant cancer cells in a manner that is specific to the disease and tissue context. The TarMeta segment built a drug discovery platform for small molecule inhibitors targeting cancer. The company was founded by Maria Vilenchik and Michael Frid on May 4, 2012 and is headquartered in Natick, MA. | Commercial Services |
Pharmaceutical Associates, Inc.
Pharmaceutical Associates, Inc. Pharmaceuticals: MajorHealth Technology Part of Beach Products, Inc., Pharmaceutical Associates, Inc. is a leading manufacturer and marketer of generic liquid pharmaceuticals. The private company is based in Greenville, SC. The company has been producing better-targeted suspensions, oral solutions, elixirs, syrups, and liquids for almost 50 years. The company offers standard bottle packaging and ready-to-dispense packaging to meet the unique needs of retail chains, independent pharmacies, hospitals, long-term care facilities, and government agencies. Pharmaceutical Associates was the first independent manufacturer to develop vertically integrated unit-dose (ud) packaging and the first to offer complete lines of hard-to-find liquid products in both out-patient and ud packaging. The CEO of the company is Kurt J. Orlofski. | Health Technology |
- Stock Market
- Insiders
- Michael Kody
- Experience